Article Data

  • Views 3516
  • Dowloads 185

Original Research

Open Access

ERECTILE DYSFUNCTION IN MEN WITH TYPE 2 DIABETES: IS IT ASSOCIATED WITH POOR GLYCEMIC CONTROL?

  • Turky H Almigbal1

1Assistant Professor and Consultant, Family Medicine, Diabetes and Chronic Disease, Department of Family and Community Medicine, Medical College, King Saud University, Riyadh, Saudi Arabia

DOI: 10.22374/jomh.v15i1.104 Vol.15,Issue 1,March 2019 pp.12-22

Published: 22 March 2019

*Corresponding Author(s): Turky H Almigbal E-mail: almogbal@yahoo.com

Abstract

Background and Objective

Erectile dysfunction (ED) is a widespread clinical issue with many new cases diagnosed every year. The prevalence of ED in men with type 2 diabetes millitus (T2DM) ranges from 35–90%, depending on patient characteristics and the method used to diagnose it. There is inconsistent evidence about the association between ED and the degree of glycemic control in men with T2DM. Our main objective was to investigate the association between ED in patients with T2DM and poor glycemic control, as well as other factors.

Material and Methods

This is a cross-sectional study based on a self-administrated questionnaire. The study was conducted from July to September 2017at King Saud University-Medical City, Riyadh, Saudi Arabia. Participants in this study were older than 18-years-old. The data from the questionnaire were analyzed using the SPSS program (Armonk, NY, USA).

Results

The prevalence of ED is 80.5%, while a severe degree is seen at 33%. There were several factors signifi-cantly associated with it, including age (p-value = 0.01), education level (p-value = 0.01), monthly income (p-value = 0.01), occupation status (p-value = 0.01), duration of diabetes (p-value = 0.01), type of treatment of diabetes (p-value = 0.01), and diabetes status (p-value = 0.01). Increasing age (above 60 years of age), duration, and uncontrolled diabetes were associated with a high risk of developing ED.

Conclusion

ED was highly prevalent in patients with T2DM and poor glycemic control, as well as advanced age and duration of diabetes: each was associated with increased risk of ED.

Keywords

Erectile dysfunction, diabetes, sexual dysfunction, glycemic control, Saudi Arabia

Cite and Share

Turky H Almigbal. ERECTILE DYSFUNCTION IN MEN WITH TYPE 2 DIABETES: IS IT ASSOCIATED WITH POOR GLYCEMIC CONTROL?. Journal of Men's Health. 2019. 15(1);12-22.

References

1. Impotence: Nih consensus development panel on im-potence. JAMA 1993;270(1):83–90.

2. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psy-chosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151(1):54–61.

3. Nikoobakht M, Nasseh H, Pourkasmaee M. The rela-tionship between lipid profile and erectile dysfunction. Int J Impot Res 2005;17(6):523–6.

4. Austoni E, Mirone V, Parazzini F, et al. Smoking as a risk factor for erectile dysfunction: data from the andrology prevention weeks 2001–2002: a study of the Italian So-ciety of Andrology (SIA). Eur Urol 2005;48(5):810–8.

5. Montorsi P, Ravagnani PM, Galli S, et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol. 2005;96(12):19–23.

6. Gazzaruso C, Giordanetti S, De Amici E, et al. Relation-ship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004;110(1):22–6.

7. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009;6(5):1232–47.

8. AlMogbel TA. Erectile dysfunction and other sexual activity dysfunctions among Saudi type 2 diabetic patients. Int J Health Sci 2014;8(4):347.

9. Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25(11):1603–10.

10. De Berardis G, Franciosi M, Belfiglio M, et al. Erectile dysfunction and quality of life in type 2 diabetic patients a serious problem too often overlooked. Diabetes care 2002;25(2):284–91.

11. Braun M, Wassmer G, Klotz T, Reifenrath B, et al. Epidemiology of erectile dysfunction: results of the Cologne Male Survey’. Int J Impot Res 2000;12(6):305–11.

12. Nicolosi A, Moreira ED, Shirai M, Tambi MIBM, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the preva-lence and correlates of erectile dysfunction. Urology 2003;61(1):201–6.

13. Balde N, Diallo A, Balde M, et al., editors. [Erectile dysfunction and diabetes in Conakry (Guinea): fre-quency and clinical characteristics from 187 diabetic patients]. Ann Endocrinol (Paris);2006.

14. El-Sakka AI, Tayeb KA. Erectile dysfunction risk fac-tors in noninsulin dependent diabetic Saudi patients. J Urol 2003;169(3):1043–7.

15. Cho N, Ahn C, Park J, et al. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mel-litus. Diabet Med 2006;23(2):198–203.

16. Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol 2000;163(3):788–91.

17. Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erec-tile dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):204–9.

18. Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reprod Biol Endocrinol 2010;8(1):1.

19. Al-Turki YA. Erectile dysfunction among diabetic patients in Saudi Arabia: a hospital-based primary care study. J Family Community Med 2007;14(1):19.

20. Shamloul R, Ghanem H, Abou-Zeid A. Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res 2004;16(5):452–5.

21. Rosen RC, Wing RR, Schneider S, et al. Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med 2009;6(5): 1414–22.

22. Health NIo. National Heart, Lung and Blood Insti-tute (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: The evidence report. Obes Res 2006;6(2).

23. Chobanian AV, Bakris GL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560–71.

24. Panel NCEPNE. Third report of the National Cho-lesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143.

25. Association AD. Standards of medical care in diabetes—2015: summary of revisions. Diabetes Care 2015;38(Supplement 1):S4-S.

26. Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reprod Biol Endocrinol 2010;8(1):50.

27. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007;120(2):151–7.

28. Al-Quwaidhi A, Pearce M, Critchley J, Sobngwi E, O’Flaherty M. Trends and future projections of the prevalence of adult obesity in Saudi Arabia, 1992-2022. East Mediterr Health J 2014;20(10):589.

29. Fareed M, Salam N, Khoja AT, Abdulrahman M. Life style related risk factors of type 2 diabetes mellitus and its increased prevalence in Saudi Arabia: A brief review. Health Sci 2017;6(3):125–32.

30. Thompson IM, Tangen CM, Goodman PJ, et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294(23):2996–3002.

31. Thethi TK, Asafu-Adjaye NO, Fonseca VA. Erectile dysfunction. Clin Diabetes 2005;23(3):105–13.

32. Khatib FA, Jarrah NS, Shegem NS, Bateiha AM, Abu-Ali RM, Ajlouni KM. Sexual dysfunction among Jordanian men with diabetes. Saudi Med J 2006;27(3):351.

33. Viera AJ, Clenney TL, Shenenberger DW, Green GF. Newer pharmacologic alternatives for erectile dysfunc-tion. Am Fam Physician 1999;60(4):1159–66, 69, 72.

34. Al Helali NS, Abolfotouh MA, Ghanem HM. Pattern of erectile dysfunction in Jeddah city. Saudi Med J 2001;22(1):34–8.

35. Lu CC, Jiann BP, Sun CC, et al. Association of glyce-mic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med 2009;6(6):1719–28.

36. McCulloch D, Campbell I, Wu F, Prescott R, Clarke

B. The prevalence of diabetic impotence. Diabetologia 1980;18(4):279–83.

37. Mofid A, Seyedalinaghi S, Zandieh S, Yazdani T, Jam 

S. Prevalence and risk factors of erectile dysfunction in Iranian diabetic men. Acta Med Iran 2009;47(4):309–14.

38. Al-Hunayan A, Al-Mutar M, Kehinde EO, et al. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int 2007;99(1):130–4.

39. Zheng H, Fan W, Li G, Tam T. Predictors for erectile dysfunction among diabetics. Diabetes Res Clin Pract 2006;71(3):313–9.

40. Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med 2010;7(1pt1):156–65.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.7 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (https://kanalregister.hkdir.no/publiseringskanaler/Forside).

Submission Turnaround Time

Conferences

Top